JDRF's Focus Areas
JDRF has been part of every advancement in type 1 diabetes (T1D) care in the last 50 years. As the world’s largest funder of T1D research, we collaborate, connect and co-ordinate the world’s greatest minds to deliver tangible improvements for the T1D community.
Through our tireless representation of the challenges facing the T1D community we have, in partnership with our advocates, delivered real change. We have changed how Governments view type 1 diabetes and delivered nearly $500m in new investment in T1D in 10 years.
A community driven organisation founded to support Australians living with type 1 diabetes, the T1D community is our focus. From first diagnosis through to living with T1D as an adult, our resources, staff, and community are with you each step of the way.
Changing the world is challenging and expensive. People from a range of backgrounds have provided JDRF significant support, whether it is leaving a bequest or participating in events like the One Walk. These funds have been crucial for supporting research.
Get the latest updates from JDRF as we lead the fight against type 1 diabetes
The researchers changing the future of type 1 diabetes
JDRF-funded Professors Jenny Couper, Simon Barry and Toby Coates on their research projects and their hopes for the future of T1D.
JDRF's latest news
JDRF supports a medical corridor in the Middle East
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access to lifesaving supplies and medicines, like insulin, needed by all people living with T1D in the Middle East conflict zone. At all times, including times […]
$3 million invested to understand and prevent the development of T1D
JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley) have committed $3 million for research projects aimed at understanding how type 1 diabetes (T1D) develops, with the ultimate goal of preventing it. This is in collaboration with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. ENDIA is the world’s first T1D observational […]
Advocacy Spotlight: Meet Joanne & Dougal
Dougal has been living with type 1 diabetes (T1D) since the age of 4, a journey that began when he complained of sore legs. Despite the absence of any family history of T1D, Joanne (Jo), a health professional and parent, quickly recognised the signs, drawing on her expertise and a colleague’s experience as a T1D […]
Community Spotlight: Meet Cara & Mya
We recently sat down with an incredible mother, Cara, who has experienced the profound journey of caring for her young daughter Mya, with type 1 diabetes (T1D). Cara shares her diagnosis story, offers valuable insights into managing T1D day-to-day, and explains why she signed up for One Walk to fundraise for JDRF. Her hope for […]
Update: Airport security and type 1 diabetes technology (January 2024)
JDRF Australia recently provided an update on type 1 diabetes (T1D) technology and airport security screening following on from conversations with the Department of Home Affairs (DHA). Since this update, we have received further reports from passengers with T1D technologies having issues accessing screening alternatives and being required to proceed through screening that they are […]
Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated
We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes (T1D), thanks to JDRF-funded Australian research that was published this week in the prestigious Nature journal. Why is this research important? During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in […]
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, […]
New research funding may allow those with type 1 diabetes to make insulin again
JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes: new funding announced
JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells. During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]